BR9007783A - BENZOYLBENZENE-, BYPHENYL-E 2-OXAZOL-ALKANOIC ACID DERIVATIVES REPLACED AS PLA2 AND LIPOXYGENASE INHIBITORS - Google Patents

BENZOYLBENZENE-, BYPHENYL-E 2-OXAZOL-ALKANOIC ACID DERIVATIVES REPLACED AS PLA2 AND LIPOXYGENASE INHIBITORS

Info

Publication number
BR9007783A
BR9007783A BR909007783A BR9007783A BR9007783A BR 9007783 A BR9007783 A BR 9007783A BR 909007783 A BR909007783 A BR 909007783A BR 9007783 A BR9007783 A BR 9007783A BR 9007783 A BR9007783 A BR 9007783A
Authority
BR
Brazil
Prior art keywords
byphenyl
benzoylbenzene
pla2
oxazol
acid derivatives
Prior art date
Application number
BR909007783A
Other languages
Portuguese (pt)
Inventor
Amedeo Arturo Failli
Anthony Frank Kreft Iii
John Henry Musser
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9007783A publication Critical patent/BR9007783A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/40—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR909007783A 1989-10-27 1990-10-27 BENZOYLBENZENE-, BYPHENYL-E 2-OXAZOL-ALKANOIC ACID DERIVATIVES REPLACED AS PLA2 AND LIPOXYGENASE INHIBITORS BR9007783A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42767789A 1989-10-27 1989-10-27
PCT/US1990/006252 WO1991006538A1 (en) 1989-10-27 1990-10-27 Substituted benzoylbenzene-, biphenyl- and 2-oxazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase

Publications (1)

Publication Number Publication Date
BR9007783A true BR9007783A (en) 1992-08-11

Family

ID=23695804

Family Applications (1)

Application Number Title Priority Date Filing Date
BR909007783A BR9007783A (en) 1989-10-27 1990-10-27 BENZOYLBENZENE-, BYPHENYL-E 2-OXAZOL-ALKANOIC ACID DERIVATIVES REPLACED AS PLA2 AND LIPOXYGENASE INHIBITORS

Country Status (11)

Country Link
EP (1) EP0497888A1 (en)
JP (1) JPH05502021A (en)
KR (1) KR927003552A (en)
AU (1) AU647425B2 (en)
BR (1) BR9007783A (en)
CA (1) CA2067138A1 (en)
FI (1) FI921864A0 (en)
HU (1) HUT64750A (en)
IE (1) IE903874A1 (en)
PT (1) PT95690A (en)
WO (1) WO1991006538A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021576A (en) * 1989-10-27 1991-06-04 American Home Products Corporation 2-Anilino phenylacetic acid derivatives
US5229516A (en) * 1989-10-27 1993-07-20 American Home Products Corporation Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
US5290798A (en) * 1991-09-30 1994-03-01 Merck Frosst Canada, Inc. (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5190968A (en) * 1991-09-30 1993-03-02 Merck Frosst Canada, Inc. (Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5308850A (en) * 1991-09-30 1994-05-03 Merck Frosst Canada, Inc. (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5374635A (en) * 1993-03-29 1994-12-20 Merck Frosst Canada, Inc. Furo[3,2-b]pyridines and thieno[3,2-b]pyridines as inhibitors of leukotriene biosynthesis
AU684316B2 (en) * 1993-10-15 1997-12-11 Shionogi & Co., Ltd. Oxazolinone derivative having intracellular phospholipase A2 inhibitor activity
IL141786A0 (en) * 1998-09-17 2002-03-10 Bristol Myers Squibb Co A pharmaceutical composition for treating diabetes containing an ap2 inhibitor
US20070043512A1 (en) * 2003-03-26 2007-02-22 Michael Rolph Therapeutic and prophylactic compositions and uses therefor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1710984A (en) * 1923-03-14 1929-04-30 Ingram Harry Closure for tumblers, jars, and other containers
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
US4659728A (en) * 1985-02-25 1987-04-21 American Home Products Corporation Hydroxy substituted 4,5-diphenyl-2-oxazole propanoic acid
US4681940A (en) * 1985-11-19 1987-07-21 American Home Products Corporation 5-[3-[[2-quinolyl]methoxy]phenyl]-1,3-oxazoles
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920133A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4

Also Published As

Publication number Publication date
FI921864A (en) 1992-04-24
JPH05502021A (en) 1993-04-15
AU647425B2 (en) 1994-03-24
PT95690A (en) 1991-09-13
HUT64750A (en) 1994-02-28
HU9201395D0 (en) 1992-07-28
EP0497888A1 (en) 1992-08-12
WO1991006538A1 (en) 1991-05-16
CA2067138A1 (en) 1991-04-28
AU6722090A (en) 1991-05-31
KR927003552A (en) 1992-12-18
IE903874A1 (en) 1991-05-08
FI921864A0 (en) 1992-04-24

Similar Documents

Publication Publication Date Title
BR9007790A (en) DERIVATIVES OF INDOL-, INDENO-, PYRANINDOL-AND TETRAHYDROCARBAZOL-ALKANOIC ACIDS REPLACED AS PLA2 AND LIPOXYGENASE INHIBITORS
PT1371647E (en) PYRIDINE-3-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS INTERMEDIARIES
BR9510256A (en) Derivatives of 3-aryl-tetronic acid
PT993439E (en) 4-BROMINE OR 4-IODOPHENYLAMINOBENZYDROXYM ACID DERIVATIVES AND THEIR USE AS MEK INHIBITORS
PT0900782E (en) ESTER OF 2-CYANACRYLIC ACID
BR9307411A (en) Aqueous composition of indicator gel
IT1217685B (en) HMG COA INHIBITORS REDUCED CONTAINING PHOSPHORUS AND METHOD FOR THEIR USE
PT888359E (en) DERIVATIVES OF PYRIMIDIN-4-ONA AS PESTICIDE
PT977733E (en) ARYLSULPHONYLAMINO-HYDROXAMIC ACID DERIVATIVES
BR9605394A (en) Oximasulfonic acid esters and their use as latent sulfonic acids
PT88075A (en) TISSUE FACTOR INHIBITOR ISOLATION METHOD
PT937036E (en) SUBSTITUTED DERIVATIVES OF 4-BIPHENYL-4-HYDROXIBUTIRICO ACID AS MATRIX METALOPROTEASE INHIBITORS
BR9007789A (en) 2-ANYLINE PHENYLACETIC ACID DERIVATIVES AS PLA2 AND LIPOXYGENASE INHIBITORS
BR9007783A (en) BENZOYLBENZENE-, BYPHENYL-E 2-OXAZOL-ALKANOIC ACID DERIVATIVES REPLACED AS PLA2 AND LIPOXYGENASE INHIBITORS
PT915837E (en) GLIOXYLIC ACID DERIVATIVES
DK0422975T3 (en) Alpha-glucosidase inhibitors
DE69024922D1 (en) Power amplifier
PT1097159E (en) USE OF PHOSPHANIC AND PHOSPHONIC ACID DERIVATIVES AS MEDICINES
FI962880A0 (en) Process and intermediates for the preparation of naphthyridonecarboxylic acid salts
PT929517E (en) HYDROXYLIC ACID DERIVATIVES
FR2613000B1 (en) REPAIR TAPE
BR8805358A (en) TIADIAZABICICLONONANO DERIVATIVE AND HERBICIDE COMPOSITION
PT87198A (en) MILL OF HAMMERS
PT876367E (en) DERIVATIVES OF TRANS-APOVINCAMINIC ACID ESTERS USED AS DRUGS
DE59510372D1 (en) USE OF BIO-ASSIMILABLE AQUEOUS BORON COMPOUNDS TO COMBAT SUBVIRUSAL DISEASES

Legal Events

Date Code Title Description
KF Request for proof of payment of annual fee
FD5 Application fees: dismissal - article 86 of industrial property law